Page contentsPage contents Shortage information Key facts Key dates Related medicine information Related shortage information Shortage information Mimpara has now been discontinued and is no longer available. Key facts Medicines affected Mimpara Supply shortage status Medicine discontinued International non-proprietary name (INN) or common name cinacalcet Therapeutic area (MESH) HypercalcemiaParathyroid NeoplasmsHyperparathyroidism Pharmaceutical forms affected TabletGranules in capsule Strengths affected 30, 60, 90mg (tablets)1, 2.5, 5mg (granules in capsule) Availability of alternatives Yes Key dates First published 07/04/2025 Last updated 03/06/2026 Related medicine information Mimpara Information on shortages and national shortage registers Medicine Shortages Single Point of Contact (SPOC) Working Party National competent authorities (human) Eligible healthcare professionals' organisations Eligible patients and consumers' organisations Related shortage information Medicine shortage communications (MSC) Medicine shortage communication (MSC): Mimpara (cinacalcet) English (EN) (110.26 KB - PDF)First published: 07/04/2025 View Share this page